SPARK-BIH National GCT Webinar — Fireside Chat "From Science to Investment: Venture Capital in Gene and Cell Therapy"

From breakthrough science to transformative therapies, gene and cell therapy is changing what’s possible in medicine. But where is the field heading next — and what does this mean for investors?

In this webinar, we will unpack the trends, opportunities, and challenges shaping the next generation of gene and cell therapies in conversation with relevnt VCs from the sector.

  • Borja Ruiz as MedicalDoctor, Board-Certified Cardiologist, and MBA graduate from London Business School. He is a Principal at InvivoVentures, the venture capital arm of InvivoPartners.
  • Daniel Sieiro from Sofinnova Partners as a Senior Associate in the Capital Strategy team. Before moving to industry, he was a research fellow at Harvard Medical School and Brighamand Women’s Hospital.
  • Emeric Nouailhac from Angelini Ventures as an Investor. He has PharmD from Université Paris Cité and a Master's in Management from ESSEC Business School.

Join us for a candid fireside conversation with leading VCs!

 

More information below in the flyer.

RegistrationHERE

SPARK-BIH is a member of the SPARK Global network